Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s Laboratories launches generic version of Zemplar Injection in US market
>>
Dr Reddys Holdings submits disclosures
>>
Dr Reddys Laboratories informs about press release
>>
Dr. Reddy's expands strategic collaboration with Amgen
>>
Dr. Reddy’s Lab trades in fine fettle on the bourses
>>
Dr. Reddy’s Laboratories features on Dow Jones Sustainability Indices 2016
>>
Dr. Reddy’s Laboratories trades higher on the bourses
>>
Dr. Reddy’s Laboratories gains on launching Bupropion HCI Tablets in US market
>>
Dr. Reddy’s Laboratories launches Bupropion HCI Tablets in US market
>>
Dr. Reddy’s Lab gains on launching unique patient-centric platform 'Purple Health'
<<
<
95
96
97
...145
>
>>